Reports for ELVIUM LIFE SCIENCES
Company Name
ELVIUM LIFE SCIENCES
Totals |
||
Shortage reports |
158 |
|
| Actual shortage: | 1 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 154 (97%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 2 (50%) | |
| Discontinued: | 2 (50%) | |
| Reversed: | 0 (0%) | |
Late reports |
2 (1%) |
|
Overdue reports |
1 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2021-12-02 | 2021-12-23 | 150348 |
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-04-15 | 2022-04-29 | 158913 |
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Avoided shortage | 2023-02-03 | 2023-02-16 | 183530 |
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-06-20 | 2023-06-24 | 195939 |
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-08-08 | 2023-08-18 | 201413 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2021-11-29 | 2021-12-17 | 150147 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-01-11 | 2022-02-26 | 152465 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-03-21 | 2022-05-04 | 157052 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-05-20 | 2022-06-01 | 161057 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-02-09 | 2023-02-17 | 184298 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-04-05 | 2023-04-14 | 188874 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2025-07-09 | 2025-07-16 | 262341 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-01-11 | 2022-02-17 | 152470 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-03-25 | 2022-04-04 | 157368 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-07-22 | 2022-07-30 | 165258 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-08-18 | 2022-09-28 | 166986 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-10-20 | 2022-11-07 | 172316 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-11-17 | 2022-12-21 | 175191 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-01-05 | 2023-02-17 | 179942 |
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-02-17 | 2023-03-28 | 185068 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRUSOPT | 2% | SOLUTION | To be discontinued | 2025-09-12 | 2025-09-12 | 267046 |
| TRUSOPT | 2% | SOLUTION | Discontinued | 2025-09-26 | 2025-12-10 | 267941 |
| TRUSOPT PRESERVATIVE-FREE | 2% | SOLUTION | Discontinued | 2025-04-04 | 2025-04-04 | 254081 |
| UNIPHYL | 400MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2021-02-01 | 2021-02-01 | 133063 |
Showing 1 to 4 of 4